Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Rutkowski

Showing results (231-240 of 491) with videos related to

Pageof 50
Sort By:
Journal of Cancer|September 14, 2018
Genetic polymorphisms may influence the vertical growth rate of melanomaMariusz Sikora, Lidia Rudnicka, Barbara Borkowska, et al.
Pediatric Blood & Cancer|September 25, 2014
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective studyAnnemiek M van Maldegem, Charlotte Benson, Piotr Rutkowski, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 9, 2026
Long-term efficacy of radical treatment of patients with clear cell sarcomaAnna M Czarnecka, Piotr Błoński, Paulina Chmiel, et al.
Journal of Clinical Medicine|August 6, 2020
Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical TrialHanna Koseła-Paterczyk, Mateusz Spałek, Aneta Borkowska, et al.
Journal of Chemotherapy (Florence, Italy)|July 8, 2024
Real-world outcomes of metastatic clear cell sarcoma sequential chemotherapyAnna M Czarnecka, Paulina Chmiel, Piotr J Błoński, et al.
Cancer Immunology, Immunotherapy : CII|January 25, 2022
Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidenceAnna Małgorzata Czarnecka, Paweł Sobczuk, Paweł Rogala, et al.
Contemporary Oncology (Poznan, Poland)|January 26, 2022
Mutational landscape of primary and recurrent Ewing sarcomaPaulina Jagodzińska-Mucha, Paweł Sobczuk, Michał Mikuła, et al.
Cancers|September 28, 2023
Mesenchymal Chondrosarcoma from Diagnosis to Clinical TrialsMonika Dudzisz-Śledź, Monika Kondracka, Monika Rudzińska, et al.
Journal of Cancer|January 18, 2020
Signatures of circulating microRNA in four sarcoma subtypesHanna Kosela-Paterczyk, Agnieszka Paziewska, Maria Kulecka, et al.
Cancers|December 11, 2022
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish ReportJoanna Placzke, Paweł Teterycz, Pietro Quaglino, et al.
Pageof 50

Showing results (231-240 of 491) with videos related to

Sort By:
Pageof 50
Journal of Cancer|September 14, 2018
Genetic polymorphisms may influence the vertical growth rate of melanomaMariusz Sikora, Lidia Rudnicka, Barbara Borkowska, et al.
Pediatric Blood & Cancer|September 25, 2014
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective studyAnnemiek M van Maldegem, Charlotte Benson, Piotr Rutkowski, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 9, 2026
Long-term efficacy of radical treatment of patients with clear cell sarcomaAnna M Czarnecka, Piotr Błoński, Paulina Chmiel, et al.
Journal of Clinical Medicine|August 6, 2020
Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical TrialHanna Koseła-Paterczyk, Mateusz Spałek, Aneta Borkowska, et al.
Journal of Chemotherapy (Florence, Italy)|July 8, 2024
Real-world outcomes of metastatic clear cell sarcoma sequential chemotherapyAnna M Czarnecka, Paulina Chmiel, Piotr J Błoński, et al.
Cancer Immunology, Immunotherapy : CII|January 25, 2022
Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidenceAnna Małgorzata Czarnecka, Paweł Sobczuk, Paweł Rogala, et al.
Contemporary Oncology (Poznan, Poland)|January 26, 2022
Mutational landscape of primary and recurrent Ewing sarcomaPaulina Jagodzińska-Mucha, Paweł Sobczuk, Michał Mikuła, et al.
Cancers|September 28, 2023
Mesenchymal Chondrosarcoma from Diagnosis to Clinical TrialsMonika Dudzisz-Śledź, Monika Kondracka, Monika Rudzińska, et al.
Journal of Cancer|January 18, 2020
Signatures of circulating microRNA in four sarcoma subtypesHanna Kosela-Paterczyk, Agnieszka Paziewska, Maria Kulecka, et al.
Cancers|December 11, 2022
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish ReportJoanna Placzke, Paweł Teterycz, Pietro Quaglino, et al.
Pageof 50